Package 76864-209-02

{"route": ["ORAL"], "spl_id": "2a4622c1-eef5-28e2-e063-6294a90abbfa", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "04JA59TNSJ"], "rxcui": ["1370427"], "spl_set_id": ["8e928b79-2178-47ef-8427-6bb57f143261"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Procaps S.A. de C.V."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (76864-209-02)  / 120 mL in 1 BOTTLE, PLASTIC", "package_ndc": "76864-209-02", "marketing_start_date": "20210603"}], "brand_name": "BACZOL EXPECTORANT", "product_id": "76864-209_2a4622c1-eef5-28e2-e063-6294a90abbfa", "dosage_form": "SYRUP", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "76864-209", "generic_name": "GUAIFENESIN, PHENYLEPHRINE HCl", "labeler_name": "Procaps S.A. de C.V.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "BACZOL EXPECTORANT", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "200 mg/5mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/5mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210603", "listing_expiration_date": "20261231"}